gene_symbol
UNKNOWN
binding_type
antigen recognition
cytotoxicity
NO
cytotoxicity_type
INDIRECT
cytotoxicity_mechanism
The vaccine primes TCRαβ+ T cells via APC-presented neoantigen peptides; the activated T cells then kill tumor cells displaying those neoantigens. TCRαβ-expressing cells themselves are not targeted or killed by the drug.
enzyme_product
Off
epitope
Off
variant
Off
isoform
Off
hla_specific
On
gated
Off
other_modifier
Recognizes peptide–HLA complexes on APCs; drives CD8+/CD4+ T-cell responses
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT06751966
disease_id_num_tar_ref
5988
drug_id_num_tar_ref
16236